NCT03567031

Brief Summary

The study aims at assessing cerebral blood flow variations following expired CO2 variations in anaesthetized infants less than 6 months, during a routine general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 27, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 25, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2019

Completed
Last Updated

October 3, 2019

Status Verified

October 1, 2019

Enrollment Period

1.3 years

First QC Date

May 23, 2018

Last Update Submit

October 2, 2019

Conditions

Keywords

Pediatric AnesthesiaNear-Infrared SpectroscopyEnd-Tidal CO2Cerebral Blood Flow

Outcome Measures

Primary Outcomes (1)

  • NIRS variation

    Near-Infrared Spectroscopy value variation after EtCO2 modification

    5 to 10 minutes

Secondary Outcomes (1)

  • DTC variation

    5 to 10 minutes

Study Arms (1)

Main Arm

EXPERIMENTAL

In each patient, under ongoing standard general anesthesia in a stable state, EtCO2 is manually modified to reach predefined values, and after waiting until cerebral blood flow has reached steady state, NIRS and DTC values are noted.

Procedure: EtCO2 modification

Interventions

Controlled modification of EtCO2 through modification of ventilation parameters under general anesthesia without spontaneous breathing

Main Arm

Eligibility Criteria

AgeUp to 6 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age \< or = 6 months
  • ASA class \< or = 3
  • General anesthesia required for surgery

You may not qualify if:

  • No parental consent
  • Emergency surgery
  • Preexisting neurological condition
  • Hemodynamic instability
  • Preexisting hypoxemia and/or hypercapnia
  • Laparoscopy or thoracoscopy, if expected EtCO2 level achieving would require unsafe ventilation parameters

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sainte Justine's Hospital

Montreal, Quebec, H3T 1C5, Canada

Location

Study Officials

  • Bruno Greff, MD

    Sainte Justine's Hospital

    PRINCIPAL INVESTIGATOR
  • Ossam Rhondali, MD

    Sainte Justine's Hospital

    STUDY DIRECTOR
  • Jose Luis Martinez, MD

    Sainte Justine's Hospital

    STUDY CHAIR
  • Chantal Crochetière, MD

    Sainte Justine's Hospital

    STUDY CHAIR
  • Valérie Gaspard, MD

    Sainte Justine's Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Patient is under general anesthesia
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Cerebral blood flow is measured in each patient at 3 different, controlled levels of end-tidal CO2
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 23, 2018

First Posted

June 25, 2018

Study Start

November 27, 2017

Primary Completion

March 3, 2019

Study Completion

March 3, 2019

Last Updated

October 3, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations